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Objective: Wnt/b-catenin signaling plays an integral and complex role in cartilage development and
maintenance. b-catenin signaling has been linked to osteoarthritis (OA), but the role of Lrp6-mediated
Wnt/b-catenin signaling during OA remains unexplored. Mutations in the Wnt/b-catenin co-receptors
LRP5 and LRP6 (low-density lipoprotein-related receptors 5 and 6) result in skeletal abnormalities,
which tend to be more severe in Lrp6 mutant mice. We examined OA development, chondrocyte and
osteoblast behavior, and b-catenin signaling after ligament and meniscus damage in mice with global
heterozygous deletion of Lrp6.
Design: Ligament and meniscus damage was surgically induced in Lrp6þ/ and wild-type (WT) mice, and
evidence of joint disease was assessed by Microcomputed tomography (micro-CT) and histology. Wnt/b-
catenin signaling, proliferation, apoptosis, chondrogenesis, osteogenesis, and catabolic enzyme activity
were measured.
Results: Relative to WT mice, Lrp6þ/ mice had lower nuclear b-catenin signaling within articular
cartilage. After surgery, osteophytes and reduced articular cartilage were apparent in WT mice, but more
severe in Lrp6þ/ animals. Impairments to trabecular bone geometry occurred for WT and Lrp6þ/ mice
after surgery. Relative to WT mice, Lrp6þ/ mice had reduced trabecular BMD and thickness, and Cyclin
D1 and Lrp6 gene expression after surgery. There was an increase in apoptotic cells and serum matrix
metalloproteinase-9 (MMP9) for Lrp6þ/ mice after surgery, but no differences in cell proliferation
occurred.
Conclusions: Heterozygous loss-of-function mutation in Lrp6 leads to less b-catenin signaling within
articular cartilage and to increased degenerative joint disease after ligament and meniscus injury.
Modulation of Lrp6 function could attenuate joint disease after damage to ligaments and the meniscus.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a degenerative joint disease that affects
millions of people; if left untreated, it can lead to loss of joint
function1. Patients often present with cartilage degradation, bone
spur (osteophyte) formation, joint space narrowing and patholog-
ical hardening of subchondral bone (sclerosis). Currently there is no
preventive or regenerative therapy for OA, and research has focused.M. Joiner, Center for Skeletal
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616-234-5721.
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s Research Society International. Pon discovering molecular pathways and targets that may be suit-
able for drug development2.
The Wnt/b-catenin signaling pathway affects cell migration, pro-
liferation, and differentiation and is a key regulator of cartilage
developmentanddegeneration3,4.Wnts forma familyof cysteine-rich
glycoproteins that bind to a member of the Frizzled family of seven-
transmembrane proteins and to either low-density lipoprotein-
related receptor 5 (Lrp5) or Lrp65. The formation of this complex
results in the phosphorylation of the carboxyl terminus of Lrp5/6,
creating a binding site for axin. Axin is a component of amulti-protein
complex that includes the adenomatous polyposis coli (APC) protein
and glycogen synthase kinase 3 (GSK3), a serine/threonine protein
kinase. In the absence of an upstream signal, this latter complex fa-
cilitates the phosphorylation and ubiquitination of b-catenin, leading
to its proteolysis. The binding of axin to phosphorylated Lrp6 inhibitsublished by Elsevier Ltd. All rights reserved.
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cytoplasmand also in the nucleus,where it complexeswithmembers
of the T cell factor/Lymphoid-Enhancing Factor (Tcf/Lef) family to
modulate the transcriptional activity of target promoters6,7.
Ectopic expression of b-catenin in chondrocyte lineage cells
inhibits theirdifferentiation, and increased levels of canonicalWnt/b-
catenin signaling may inhibit Sox9, a key regulator of chondro-
genesis8. Evidence of both increased and decreased b-catenin has
been reported in regions of degenerative cartilage and during OA9e11.
Col2a1-Cre-mediated conditional activation of b-catenin in adult
mice leads to cartilage degradation, surface ﬁbrillation and clefting,
and osteophyte formation10. Continuous inhibition of b-catenin in
Col2a1-expressing cells increases cartilage destruction and cell
apoptosis in mice9. b-catenin signaling may also have differential
effects on chondrocyte maturation and apoptosis, depending on the
spatial location within the knee joint12. LRP5 mRNA and protein is
increased in cells from humanOA patients, and LRP5 polymorphisms
analyzed as a group have been correlated with human OA13e15.
Studies suggest that loss-of-functionmutations in theWnt/b-catenin
co-receptor Lrp5 result in skeletal abnormalities and can lead to
cartilage damage after surgical destabilization16e19. Homozygous
deletion of Lrp6 is embryonically lethal, but conditional knockout or
heterozygous Lrp6 mice tend to develop skeletal phenotypes more
severe than those of Lrp5 mutants16,17.
Ligament and meniscus injury can alter the mechanical envi-
ronment in load-bearing joints, increase stress on the protective
articular cartilage and underlying subchondral bone, and lead to
degenerative joint disease over time20e23. Skeletal abnormalities in
Lrp6 mutant mice are more severe than those of Lrp5 mutant,
however, the role of Lrp6-mediated Wnt/b-catenin signaling during
degenerative joint disease development after ligament andmeniscus
trauma, and its effect on cell behavior and b-catenin signaling, are
unknown. Therefore we examined OA progression after mechanical
destabilization through ligament and meniscus injury in mice het-
erozygous for a germline deletion in Lrp6 (Lrp6þ/). We hypothe-
sized that Lrp6þ/micewould have reducedWnt/b-catenin signaling
and chondrocyte proliferation, as well as increased chondrocyte
apoptosis and catabolic enzyme activity after damage to ligaments
and meniscus. Furthermore, we predicted that untreated ligament
and meniscus damage in these mice would progress to degenerative
joint disease.
Materials and methods
All experimental procedures were approved by the Van Andel
Research Institute Institutional Animal Care and Use Committee
(IACUC).
Generation of mice and surgical destabilization model
Lrp6þ/ mice (a gift of W Skarnes) were generated as described
previously24. Mice (<5 per cage) were maintained in 5 in.  8 in.
(40 sq.in.) cages containing paper bedding and were under a 12 h/
12 h light/dark cycle. Mice were fed a standard mouse diet. Tran-
section of the cruciate and meniscotibial ligaments as well as
meniscus removal was performed on the right knee of 8-week-old
male Lrp6þ/ mice (n ¼ 21) and 8-week-old male wild-type (WT)
littermates (n ¼ 25) according to an adaptation of the previously
described surgical method25. The patellar tendon and collateral
ligaments were not transected. Mice were anesthetized by intra-
peritoneal injection (0.03 ml Avertin/g), and the medial menisco-
tibial ligament was sectioned to destabilize the medial meniscus.
The anterior cruciate, posterior cruciate, and lateral meniscotibial
ligaments were transected and the medial and lateral menisci were
removed. The incision was then closed with suture and stapled.Animals resumed normal ambulation within hours after surgery.
Mice were euthanized 60 d after surgery by CO2 inhalation for
endpoint analyses. The left knee of each animal was untouched and
served as a contralateral control. Surgery was not performed on 10-
week-old WT (n ¼ 3) and Lrp6þ/ (n ¼ 4) untouched control mice
that were sacriﬁced and analyzed by Microcomputed tomography
(micro-CT) and histology.
micro-CT
Knee joints of WT (n ¼ 10) and Lrp6þ/ (n ¼ 6) mice were
dissected post sacriﬁce and imaged 60 d after surgery using a
Skyscan 1172 micro-CT system (Skyscan Kontich, Belgium). Knees
from 10-week-old WT (n ¼ 3) and Lrp6þ/ (n ¼ 4) mice that did not
undergo surgerywere also dissected post sacriﬁce and imagedwith
a Skyscan 1172 micro-CT system. Samples were immersed in 1
phosphate-buffered saline (PBS) and were scanned, applying
50 kVp, 200 mA, a 0.4 rotation step, and 200ms exposure time, and
using a 0.5-mm aluminum ﬁlter. Images were reconstructed onto
10 mmvoxels. The images were ﬁltered during reconstruction using
a ring correction factor of 6, a smoothing factor of 0, and a 20%
beam-hardening correction. SkyScan software (DataViewer, CTAn,
and CTVox) was used to reorient and analyze samples in different
planes. Ligament and meniscus injury can lead to damaged
trabecular bone in the tibia26. Regions of interest within the
trabecular bone of the proximal tibia were created, and trabecular
bone volume/tissue volume (BV/TV), trabecular number, trabecular
separation, trabecular thickness, and trabecular mineralization
values were determined using SkyScan software. The region of
interest (ROI) excluded cortical bone and began below the sub-
chondral plate and extended 1 mm in the distal direction. All
measured parameters are represented as the mean  SD. Mimics
software (Materialise, Plymouth, MI) was used to create three-
dimensional reconstructions for qualitative analysis.
Histology
Knees harvested from 10-week-old WT (n ¼ 3) and Lrp6þ/
(n ¼ 4) mice that did not undergo surgery and knees harvested
from WT (n ¼ 6) and Lrp6þ/ (n ¼ 6) mice 60 d after surgery were
ﬁxed in 10% neutral buffered formalin for 48 h, followed by im-
mersion in Immunocal (Decal Chemical Corporation, Tallman,
NY) for 48 h. Samples were inﬁltrated with an alcohol series,
cleared with xylene, and inﬁltrated with parafﬁn. Samples were
embedded on edge into a parafﬁn mold using the Leica embedding
center, sectioned at 5 mm using a microtome, and then collected
onto glass slides. Sections were cut for each sample spanning a
region from the center of the lateral condyle to the center of the
medial condyle.
All staining beganwith deparafﬁnizationwith CitriSolv (Thermo
Fisher Scientiﬁc, Rockford, IL), and hydration through a progressive
series of graded alcohols followed by distilled water. Sagittal knee
sections were stained with Movats Pentachrome according to
standard protocols. Sections used for immunohistochemistry (IHC)
were quenched in 0.3% hydrogen peroxide, and antigen retrieval
was achieved by incubating sections in warmed 10 mM sodium
citrate buffer (pH 6.0) for 15 min. IHC was performed on sections
with a Vectastain ABC kit for b-catenin (CST 9562 1:200) and Ki-67
(SB M3060 1:100), as well as neutrophils, monocytes, and macro-
phages (ab75693 prediluted; the immunogen for this product is
afﬁnity puriﬁedmonocytemembrane preparation) according to the
manufacturer’s instructions (Vector Laboratories, Burlingame, CA).
IHC negative controls were incubated in blocking buffer instead of
primary antibody. Nine sections from each sample were used for
each stain. All primary antibodies were purchased from Abcam
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Spring Bioscience (Pleasanton, CA).
Stains were imaged with a Nikon Eclipse 55i microscope and a
Nikon Digital Sight camera (Melville, NY). The percentage of pixels
that stained positive for Ki-67, b-catenin and for both b-catenin and
hematoxylin were quantiﬁed with a Nuance system (Burlington,
MA). b-catenin staining in the bone marrow was excluded from
subchondral bone pixel quantiﬁcation. A terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assay was performed
according to manufacturer’s instructions to assess cellular apoptosis
(Promega, Madison, WI). Image J software was used to quantify the
area of TUNEL positive stain (U. S. National Institutes of Health,
Bethesda, Maryland, USA). Sagittal cryosections (7 mm) of knees
fromWT (n ¼ 3) and Lrp6þ/ (n ¼ 3) mice were cut with a CryoJane
tape transfer system (Leica Microsystems, Buffalo Grove, IL). Sec-
tions were incubated in 5% silver nitrate solution for 15 min under
UV, rinsed, incubated in 5% sodium thiosulfate for 5 min, rinsed, and
counterstained with hematoxylin to assess mineralization.
Three physicians blinded to the samples scored pentachrome-
stained histological sections according to an established proto-
col27. Based on this system cartilage grading was assigned with the
following scale: 0 ¼ normal cartilage, 0.5 ¼ loss of proteoglycan
stain without cartilage damage, 1 ¼ mild superﬁcial ﬁbrillation,
2 ¼ ﬁbrillation and/or clefting extending below the superﬁcial
zone, 3¼mild (<25%) loss of cartilage, 4¼moderate (25e50%) loss
of cartilage, 5 ¼ severe (50e75%) loss of noncalciﬁed cartilage, and
6 ¼ eburnation with >75% loss of cartilage27. The three grades for
each section were averaged and the data from each group of mice
were combined. The greatest perpendicular distance of articular
cartilage thickness was measured with image J software.
Real Time Polymerase Chain Reaction (RT-PCR)
Knees fromWT (n ¼ 6) and Lrp6þ/ (n ¼ 6) mice were dissected
under RNase-free conditions and homogenized in 1 ml TRIzol with
a Fast Prep-24 tissue and cell homogenizer (MP Biomedicals, Solon,
OH). RNA was chloroform-precipitated and extracted with an
RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufac-
turer’s instructions. RNA concentration was calculated and RNA
integrity analyzed using the NanoDrop 2000 (Thermo Scientiﬁc
Wilmington, DE) and Agilent 2100 Bioanalyzer (Agilent Technolo-
gies Santa Clara, CA), respectively; any potential DNA contamina-
tion was removed by RNase-free DNase treatment (Ampliﬁcation
Grade DNase I Sigma Aldrich St. Louis, MO). Complimentary DNA
was made with a RevertAid First Strand cDNA Synthesis Kit (Fer-
mentas, Glen Burnie, MD) on 0.5 mg of RNA. The ampliﬁcation of
gene products was determined by the incorporation of SYBR Green
ﬂuorescent nucleic acid stain (Fermentas, Glen Burnie, MD) and
normalized to 18s using the DDc(t) method28. RT-PCR primers were
purchased from Integrated DNA Technologies. Forward and reverse
primer sequences for measures of catabolic enzymes including
matrix metalloproteinase-3 (mmp3) and mmp13; measures of
chondrogenesis including sox9, aggrecan, and col2a1; measures of
osteogenesis including col1a1, col10a1, runx2, osterix, ocn-1, ocn-2,
and opn; Wnt/b-catenin co-receptors Lrp5 and Lrp6; Wnt/b-catenin
target genes including Cyclin D1 and c-jun; Wnt/b-catenin antag-
onists including sfrp1, sfrp2, Frzb, and sfrp4; and 18s, which was
used as a housekeeping gene, are listed in Supplemental Table 1. All
samples were assayed in duplicate.
Enzyme-linked Immunosorbent Assay (ELISA)
Several catabolic enzymes including MMP3 and MMP9 have
been linked to OA29. Serum was collected retro-orbitally from WT
(n¼ 5) and Lrp6þ/ (n¼ 5) mice at baseline and days 14, 28, 42, and60 post-surgery according to established animal protocols. Mice
used for serum analysis were also used for histology. MMP3 and
MMP9 serum concentrations were determinedwith ELISA kits from
R&D Systems (Minneapolis, MN). Brieﬂy, 50 mL of each serum
sample was added to a microplate well coated with either MMP3 or
MMP9 antibody and incubated at room temperature on an orbital
shaker. Following incubation, plates werewashed and eitherMMP3
or MMP9 monoclonal antibody was added to detect the respective
captured protein. Hydrogen peroxide and tetramethylbenzidine
solution was added and the plate was incubated at room temper-
ature for 30 min in the dark. Sulfuric acid stop solution was then
added and the optical density wasmeasured at 450 nm and 540 nm
(Benchmark Plus, Bio Rad, Hercules, CA). The readings taken at
540 nm were subtracted from the readings taken at 450 nm and
unknown sample concentrations were calculated based on values
from respective MMP3 and MMP9 standard curves. All samples
were assayed in duplicate.
Statistics
GraphPad Prism software (La Jolla, CA) was used for statistical
analysis. We used GraphPad Prism software to conﬁrm normality of
the data sets and conduct an F test to determine whether variances
were signiﬁcantly different. In the case where variances were
signiﬁcantly different we performed a log transformation on the
data set. For quantitative RT-PCR data a two-sided 95% conﬁdence
interval unpaired Student’s t test with Welch’s correctionwas used.
Repeated measure analysis was used for ELISA data. A two-way
analysis of variance (ANOVA) was used for all other quantitative
data. P values less than 0.05 were statistically signiﬁcant.
Results
Qualitative morphological differences between knees from WT
and Lrp6þ/ mice that did not have surgery and contralateral con-
trol knees from respective animals were not observed [Figs. 1(A),
2(B), Figs. S1(A), (B)]. Tibia trabecular micro-CT data for knees
from WT and Lrp6þ/ mice that did not have surgery is shown in
Supplemental Table 2 and there was no signiﬁcant difference in
these parameters relative to contralateral control knees from
respective animals. There was no qualitative difference in b-catenin
staining intensity between knees from WT and Lrp6þ/ mice that
did not have surgery and contralateral control knees from respec-
tive animals [Figs. 4(C), 5(A), Fig. S1(C)]. Articular cartilage thick-
ness, the percentage of total b-catenin pixels in the cartilage and
subchondral bone, and the percentage of nuclear b-catenin pixels in
the cartilage and subchondral bone for knees fromWT and Lrp6þ/
mice that did not have surgery is shown in Supplemental Table 3
and there was no signiﬁcant difference in these measurements
relative to contralateral control knees from respective animals.
Sixty days after ligament and meniscus surgery, osteophytes
were present in the knees of both WT and Lrp6þ/ mice, but there
were qualitativelymore bony outgrowths and less joint space in the
surgery knees of the Lrp6þ/ animals [Fig. 1(A)]. We also qualita-
tively observedmal-alignment in the surgery knees of Lrp6þ/mice
[Fig. 1(A)]. There was a signiﬁcant increase (P¼ 0.006) in trabecular
tissue mineral density with surgery for WT mice, and trabecular
mineral density was signiﬁcantly lower (P < 0.001) for surgery
knees from Lrp6þ/ mice relative to those from WT [Fig. 1(B)].
Trabecular BV fraction was signiﬁcantly lower for surgery knees
relative to control knees for WT mice (P ¼ 0.01) [Fig. 1(C)]. There
were signiﬁcantly fewer trabeculae in the surgery knees of bothWT
(P ¼ 0.006) and Lrp6þ/ mice (P ¼ 0.007) relative to respective
control knees [Fig. 1(D)]. Trabecular separation distance was
signiﬁcantly greater in surgery knees of both WT (P ¼ 0.002) and
Fig. 1. The number of animals used for each assay is referred to as “n”. A surgery knee and contralateral control knee was analyzed for each animal. (A) Three-dimensional
reconstructed micro-CT images of control and surgery knees from WT and Lrp6þ/ mice. Surgery knees from Lrp6þ/ mice had increased osteophytes (arrows) and joint space
narrowing. (B) Trabecular mineral density for control and surgery knees fromWT and Lrp6þ/mice expressed as mean  SD. (C) Trabecular BV fraction for control and surgery knees
from WT and Lrp6þ/ mice (mean  SD). (D) Number of trabeculae for control and surgery knees from WT and Lrp6þ/ mice (mean  SD). (E) Trabecular separation distance for
control and surgery knees from WT and Lrp6þ/ mice (mean  SD). (F) Trabecular thickness for control and surgery knees from WT and Lrp6þ/ mice (mean  SD).
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[Fig. 1(E)]. Trabecular thickness was also signiﬁcantly greater in
surgery knees for Lrp6þ/ mice (P ¼ 0.04) relative to controls.
However, trabecular thickness was signiﬁcantly lower in control
(P < 0.001) and surgery (P ¼ 0.01) knees of Lrp6þ/mice relative to
the corresponding knees from WT animals [Fig. 1(F)].
Fewer trabeculae were observed qualitatively in the tibia of
surgery knees of Lrp6þ/ mice relative to both knees from WT an-
imals [Fig. 2(A)]. Pentachrome stains showed tidemark absence and
cleft formation in surgery knees from Lrp6þ/ mice as well as
cartilage degradation relative to the control knee and relative to
both knees from WT animals [Fig. 2(B)]. Articular cartilage thick-
ness was signiﬁcantly lower in surgery knees from WT (P ¼ 0.003)
and Lrp6þ/ (P < 0.0001) mice relative to respective control knees
and articular cartilage thickness was signiﬁcantly lower (P ¼ 0.002)
for surgery knees from Lrp6þ/mice relative to surgery knees from
WT animals [Fig. 2(C)]. The effect of surgery on articular cartilage
thickness in WT and Lrp6þ/ mice was signiﬁcantly different
(interaction P ¼ 0.007) [Fig. 2(C)]. The histological score, which is
indicative of disease severity, was signiﬁcantly higher for Lrp6þ/
control and surgery knees relative to the corresponding knees from
WT animals (P ¼ 0.03; P ¼ 0.008 respectively) [Fig. 2(D)]. Histo-
logical score was also signiﬁcantly higher in the surgery knee
relative to the control for WT mice (P ¼ 0.04) [Fig. 2(D)].
Several osteogenic genes were up-regulated in WT and Lrp6þ/
mice in the surgery knee relative to the control, and there was an
indication of increased relative osterix (P ¼ 0.06) for Lrp6þ/ mice
relative to WT [Fig. 3(A)]. Aggrecan and sox9 were up-regulated in
surgery knees of WT and Lrp6þ/mice relative to control knees, but
col2a1 was not [Fig. 3(A)]. Mmp3 and mmp13 were up-regulated in
surgery knees of WT and Lrp6þ/mice relative to control knees, but
there was no signiﬁcant difference between genotypes (Table I).
There were no signiﬁcant differences in serum MMP3 for eithergroup over time relative to baseline measurements or betweenWT
and Lrp6þ/ mice at the measured time points [Fig. S2(A)]. Serum
MMP9 was signiﬁcantly higher than baseline for Lrp6þ/ mice at
day 14 (P ¼ 0.006) and there was an indication of increased MMP9
for Lrp6þ/mice at day 28 (P ¼ 0.05) relative to baseline [Fig. 3(B)].
There was an indication of increased MMP9 for WT mice at day 42
(P ¼ 0.05) relative to baseline and MMP9 concentration was
signiﬁcantly higher at day 42 relative to day 14 for WT animals
(P ¼ 0.009) [Fig. 3(B)]. There was an indication of higher MMP9
serum concentration for Lrp6þ/ mice relative to WT at day 14
(P ¼ 0.06) [Fig. 3(B)].
We examined monocytes, neutrophils, and macrophages to
assess inﬂammation and did not observe a qualitative difference in
staining between genotypes [Fig. S2(B)]. Proliferating cells were
present in the articular cartilage of both control and surgery knees
from WT and Lrp6þ/ animals [Fig. 3(C)]. There was no signiﬁcant
difference in Ki-67 staining between control and surgery knees for
WT and Lrp6þ/ mice or between knees from Lrp6þ/ mice relative
to respective knees from WT animals [Fig. 3(C), Fig. S2(C)].
Apoptotic cells were detected in the articular cartilage and sub-
chondral bone of surgery knees from WT and Lrp6þ/ animals
[Fig. 4(A)]. There was a signiﬁcant increase with surgery (P ¼ 0.03)
in the area of the knee joint with apoptotic cells for Lrp6þ/ mice
[Fig. 4(A, B)].
b-catenin staining within cartilage was observed qualitatively in
the knees of WT mice, but b-catenin levels were lower in the
control and surgery knees of Lrp6þ/ mice [Fig. 4(C)]. There was no
signiﬁcant difference in the number of total b-catenin pixels (a
measure of staining intensity) within articular cartilage between
control and surgery knees for either group [Fig. 4(D)]. Total articular
cartilage b-catenin staining was signiﬁcantly higher (P ¼ 0.02) in
WT surgery knees relative to Lrp6þ/ surgery knees [Fig. 4(D)]. The
intensity of nuclear b-catenin immunoreactivity within articular
Fig. 2. The number of animals used for each assay is referred to as “n”. A surgery knee and contralateral control knee was analyzed for each animal. (A) Von Kossa sagittal sections of
control and surgery knees from WT (n ¼ 3) and Lrp6þ/ (n ¼ 3) mice (2). Tibia from control and surgery knees are shown at 4 magniﬁcation. (B) Pentachrome-stained sagittal
sections of control and surgery knees from WT (n ¼ 6) and Lrp6þ/ (n ¼ 6) mice used for histological quantiﬁcation. Boxed regions of sections from surgery knees are shown at
higher magniﬁcation in the adjacent panel. Muscle, cartilage, ﬁbrin, and reticular ﬁbers are stained red, blue, bright red, and yellow, respectively. The arrow points to cartilage
degradation (blue), tidemark absence (yellow), clefts (black), and osteophytes (white). (C) Articular cartilage thickness for control and surgery knees in WT and Lrp6þ/ mice
expressed as mean  SD. (D) Histological scores for control and surgery knees from WT and Lrp6þ/ mice expressed as mean  SD.
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meniscus damage (P ¼ 0.009) and was signiﬁcantly higher in WT
control and surgery knees relative to the corresponding joints from
Lrp6þ/ animals (P < 0.001 and P < 0.001, respectively) [Fig. 4(E)].
The effect of surgery on the percentage of nuclear b-catenin in the
cartilage of WT and Lrp6þ/ mice was signiﬁcantly different
(interaction P ¼ 0.002) [Fig. 4(E)]. There was no signiﬁcant differ-
ence in subchondral bone nuclear b-catenin intensity between
control and surgery knees from WT or Lrp6þ/ mice [Fig. 5(A, B)].
Total subchondral bone b-catenin increased signiﬁcantly with
surgery in WT mice (P < 0.001) and was signiﬁcantly higher in
surgery knees of WT mice compared with surgery knees of Lrp6þ/mice (P ¼ 0.005) [Fig. 5(C)]. The effect of surgery on the percentage
of b-catenin in the subchondral bone of WT and Lrp6þ/ mice was
signiﬁcantly different (interaction P ¼ 0.006) [Fig. 5(C)].
Wnt/b-catenin antagonist gene expression was up-regulated in
surgery knees from WT and Lrp6þ/ mice compared with control
knees. There were 6.7- and 2.7-fold up-regulations of sfrp2 and
sfrp4, respectively, in WT mice, and 3.3-, 4.4-, and 3.7-fold
respective up-regulations of sfrp1, sfrp2, and sfrp4 for Lrp6þ/
mice [Fig. 6(A)]. Wnt/b-catenin co-receptor and target gene
expression in surgery knees relative to control knees was up-
regulated in WT mice and either unchanged or down-regulated
in Lrp6þ/ animals [Fig. 6(B)]. LRP6 and cyclin D1 gene expression
Fig. 3. The number of animals used for each assay is referred to as “n”. A surgery knee and contralateral control knee was analyzed for RT-PCR and histology data. (A) Osteogenic and
chondrogenic gene expression (surgery knee relative to control) expressed as mean  SD for Lrp6þ/ mice and WT littermates. 95% CI of difference: runx2 (1.547 to 0.5293), osx
(5.766 to 0.2130), ocn-1 (1.594 to 0.8688), ocn-2 (2.904 to 3.372), opn (2.838 to 0.8985), col1a1 (1.135 to 0.9276), col10a1 (0.9372 to 0.4158), aggrecan (0.5468 to 2.396),
sox9 (1.290 to 1.737), and col2a1 (0.8516 to 0.6853). (B) Serum MMP9 expressed as mean  SD for Lrp6þ/ mice and WT littermates; ## ¼ signiﬁcant difference relative to
baseline measurements and ** ¼ signiﬁcant difference between day 14 and day 42. (C) Sagittal sections of control and surgery knees fromWT (n ¼ 6) and Lrp6þ/ (n ¼ 6) mice IHC-
stained for Ki-67 (brown). Arrows point to stained cells.
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(P ¼ 0.008; P ¼ 0.003) [Fig. 6(B)].Discussion
Untreated ligament and meniscus damage progressed to an OA
phenotype that was more severe in Lrp6þ/ mice than in WTTable I
Catabolic enzyme gene expression relative to control knee
Mmp3 Mmp13
WT 38.9  38.0 3.1  2.6
Lrp6þ/ 57.4  93.0 7.6  12.4
Data is expressed as mean  SD. Mmp3 95% conﬁdence interval (99.0 to 62.1) and
mmp13 95% conﬁdence interval (15.1 to 6.0).littermates. Up-regulation of Wnt/b-catenin co-receptor and target
gene expression was accompanied by an up-regulation of antago-
nist gene expression after injury in WT mice, resulting in increased
b-catenin protein. Up-regulated Wnt/b-catenin antagonist gene
expression after injury coupled with reduced co-receptor and
target gene expression kept b-catenin protein low in Lrp6þ/ mice,
which developed a more severe OA phenotype. Aggrecan and sox9
gene expression were also up-regulated after injury in WT and
Lrp6þ/ mice, which may have been an attempt at repair; the up-
regulation was lower in mutant animals, possibly due to reduced
b-catenin signaling.
We found reductions in total subchondral bone b-catenin for
Lrp6þ/mouse surgery knees relative to such knees inWT, but there
was no signiﬁcant difference in subchondral bone nuclear b-catenin
between the genotypes. Within the articular cartilage nuclear b-
catenin was signiﬁcantly reduced in both the control and surgery
Fig. 4. The number of animals used for each assay is referred to as “n”. A surgery knee and contralateral control knee was analyzed for each animal. (A) TUNEL-stained (green)
sagittal sections of control and surgery knees from WT (n ¼ 6) and Lrp6þ/ (n ¼ 6) mice, counterstained with DAPI (blue). (B) Area of TUNEL-stained pixels in surgery and control
knees of WT and Lrp6þ/mice, expressed as mean  SD. (C) Sagittal sections of control and surgery knee articular cartilage fromWT (n ¼ 6) and Lrp6þ/ (n ¼ 6) mice IHC-stained for
b-catenin (brown). (D) Percentage of total positive-stained b-catenin pixels in articular cartilage from surgery and control knees of WT and Lrp6þ/ mice, expressed as mean  SD.
(E) Percentage of positive-stained nuclear b-catenin pixels in articular cartilage from surgery and control knees of WT and Lrp6þ/ mice expressed as mean  SD.
D.M. Joiner et al. / Osteoarthritis and Cartilage 21 (2013) 1576e15851582knees of mutant mice relative to the respective WT knees and total
b-catenin was signiﬁcantly lower for surgery knees from Lrp6þ/
mice relative to surgery knees from WT. b-catenin signaling may
playapivotal role in theentireknee joint,whichmayhave important
implications in the articular cartilage during injury-induced OA.
Lower b-catenin in cartilage could increase apoptosis and reducechondrocyte differentiation as well as cartilage integrity12,30. Loads
placed on the joints of Lrp6þ/ mice could cause further damage to
the cartilage, increase cell apoptosis and catabolic enzyme activity,
and facilitate the degradation of the protective cartilaginous layer
thus initiating subchondral bone damage after ligament and
meniscus trauma. An osteopenic phenotype has previously been
Fig. 5. The number of animals used for each assay is referred to as “n”. A surgery knee and contralateral control knee was analyzed for each animal. (A) Sagittal sections of control
and surgery knee subchondral bone from WT (n ¼ 6) and Lrp6þ/ (n ¼ 6) mice IHC-stained for b-catenin (brown). (B) Percentage of positive-stained nuclear b-catenin pixels in the
subchondral bone from surgery and control knees of WT and Lrp6þ/ mice, expressed as mean  SD. (C) Percentage of total positive-stained b-catenin pixels in subchondral bone
from surgery and control knees of WT and Lrp6þ/ mice, expressed as mean  SD.
D.M. Joiner et al. / Osteoarthritis and Cartilage 21 (2013) 1576e1585 1583reported in Lrp6þ/ mice which may exacerbate subchondral bone
damage after ligament andmeniscus injury, and couldoccur inother
animals with low bone mass16. However, the individual contribu-
tions of the low bonemass phenotype in Lrp6þ/mice and aberrant
Wnt mediated b-catenin signaling were not fully elucidated in this
study.
Structural changes at the osteochondral junction might be the
result of an altered mechanical environment, which may occur as
the articular cartilage matrix weakens and progresses to direct
bone-on-bone contact31. Previous studies showed that subchondral
bone changes adversely affect the biomechanical environment of
the overlying cartilage and lead to secondary changes in the carti-
lage structure and integrity as well as adversely affect the capacity
of cartilage to adapt to mechanical loads32. Mechanotransduction,
either in the cartilage or the subchondral bone, might play a role inFig. 6. The number of animals used for each assay is referred to as “n”. A surgery knee and
gene expression (surgery knee relative to control) expressed as mean  SD for Lrp6þ/ mice
frzb (1.866 to 2.417), and sfrp4 (6.531 to 4.616). (B) Wnt/b-catenin receptors and target ge
littermates; **P < 0.01 between genotypes. 95% CI of difference: Lrp5 (1.461 to 3.455), Lrpthe signaling cascade that leads to cartilage degradation. Both Wnt
signaling and mechanical loading are key regulators of bone and
cartilage formation. Osteocytes and osteoblasts subjected to me-
chanical loading have Tcf/Lef reporter activity and increased nu-
clear accumulation of activated b-catenin33,34. Altered Wnt
signaling through loss-of-function mutation in Lrp5 reduces the
anabolic response of bone to mechanical stimulation, and gain-of-
function mutations in Lrp5 enhance load-induced osteo-
genesis35,36. It is unknown how Lrp6 mutation inﬂuences mecha-
notransduction in bone tissue, but based on the severe skeletal
abnormalities in Lrp6 mutant mice, it is possible that they would
also have an impaired anabolic response to mechanical stimulation.
Trabecular bone mineral density may increase with surgery in
WT mice due to an anabolic adaptation to mechanical loading.
Trabecular thickness was signiﬁcantly greater in surgery knees ofcontralateral control knee was analyzed for each animal. (A) Wnt/b-catenin antagonist
and WT littermates. 95% CI of difference: sfrp1 (1.724  1.166), sfrp2 (1.170 to 5.779),
nes (surgery knee relative to control) expressed as mean  SD for Lrp6þ/mice and WT
6 (0.9966 to 4.256), c-jun (0.5058 to 3.707), and cyclin D1 (1.122 to 3.082).
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signiﬁcantly lower in control and surgery knees relative to
respective knees from WT animals. Impairments in trabecular
number and separation distance were observed in surgery knees of
Lrp6þ/mice relative to the control knees and in mineral density of
Lrp6þ/ mice surgery knees relative to surgery knees from WT
animals, but the functional biological outcome was not fully
elucidated in this study. The trabecular bone geometric properties
observed in Lrp6 mutant surgery knees could result from an
impaired adaptive response through b-catenin, to the increased
load placed on the bone as the articular cartilage degrades. Despite
impairments to trabecular bone with surgery for WT and Lrp6þ/
mice an up-regulation of osteogenic gene expression occurred
which is likely due to osteophyte formation.
The role of b-catenin signaling during injury repair has been
explored in several tissues and its effects are context-depen-
dent37,38. Although we did not observe signiﬁcant differences in the
number of Ki-67-stained cells in this study, proliferating cells have
increased b-catenin signaling, and b-catenin has been linked to
adherens junctions, which facilitate cellecell adhesion and can
disassemble, allowing cell migration during healing39,40. Recent
work suggests that neural cadherin (N-cadherin) may inhibit Wnt/
b-catenin signaling through a direct interaction with LRP541. To
date, interactions between N-cadherin and LRP6 are not fully
known, but they could inﬂuence cell adhesion and migration
thereby altering healing in Lrp6-deﬁcient mice.
The recent characterization of LRP5/6 crystal structure has also
uncovered new opportunities to target these proteins for therapeu-
tics42. Canonical Wnt inhibitors like sclerostin and Dickkopf-related
protein 1 (Dkk1) can interfere with LRP5/6 activity and have shown
promising results when used to treat human and mouse models of
various bone diseases42. Dkk1 may play a protective role in OA pro-
gression, but conﬂicting reports showup-regulatedDkk1 levels in OA
patients43,44. Our ﬁndings suggest that the inﬂuence of Wnt/b-cat-
enin signaling on OA progression may also depend on the cell type
involved, spatial locationwithin the joint, and/or the initial triggers of
joint disease. Elements of the surgical model used in our studies are
severe, but othershaveusedcomplex surgical destabilizationmodels,
including damage to both ligaments and the meniscus, to examine
the effect of therapeutics on cartilage repair27,45. Ourﬁndings suggest
an important role of LRP6 in cartilage and bone damage after trauma
to the ligaments and menisci and that modulation of LRP6 function
could be a therapeutic strategy for degenerative joint diseases that
develop after this type of injury.
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